rs7754205

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006073.4(TRDN):​c.2051-19G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.45 in 1,551,200 control chromosomes in the GnomAD database, including 160,242 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.43 ( 14141 hom., cov: 31)
Exomes 𝑓: 0.45 ( 146101 hom. )

Consequence

TRDN
NM_006073.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.929

Publications

8 publications found
Variant links:
Genes affected
TRDN (HGNC:12261): (triadin) This gene encodes an integral membrane protein found in skeletal and cardiac muscle. The encoded protein plays a role in skeletal muscle excitation-contraction coupling as part of the calcium release complex and is required for normal skeletal muscle strength. This protein indirectly links triads and microtubules in skeletal muscle. Mutations in this gene are associated with cardiac arrythmia syndrome and some variants in this gene may be associated with sudden cardiac death. [provided by RefSeq, May 2022]
TRDN Gene-Disease associations (from GenCC):
  • catecholaminergic polymorphic ventricular tachycardia
    Inheritance: AD, AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • catecholaminergic polymorphic ventricular tachycardia 5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • familial long QT syndrome
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • long QT syndrome
    Inheritance: AR Classification: STRONG Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 6-123218759-C-T is Benign according to our data. Variant chr6-123218759-C-T is described in ClinVar as Benign. ClinVar VariationId is 259915.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.542 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRDNNM_006073.4 linkc.2051-19G>A intron_variant Intron 40 of 40 ENST00000334268.9 NP_006064.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRDNENST00000334268.9 linkc.2051-19G>A intron_variant Intron 40 of 40 1 NM_006073.4 ENSP00000333984.5

Frequencies

GnomAD3 genomes
AF:
0.425
AC:
64429
AN:
151440
Hom.:
14120
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.349
Gnomad AMI
AF:
0.427
Gnomad AMR
AF:
0.551
Gnomad ASJ
AF:
0.503
Gnomad EAS
AF:
0.317
Gnomad SAS
AF:
0.288
Gnomad FIN
AF:
0.353
Gnomad MID
AF:
0.544
Gnomad NFE
AF:
0.467
Gnomad OTH
AF:
0.485
GnomAD2 exomes
AF:
0.442
AC:
71937
AN:
162720
AF XY:
0.431
show subpopulations
Gnomad AFR exome
AF:
0.358
Gnomad AMR exome
AF:
0.621
Gnomad ASJ exome
AF:
0.500
Gnomad EAS exome
AF:
0.301
Gnomad FIN exome
AF:
0.360
Gnomad NFE exome
AF:
0.475
Gnomad OTH exome
AF:
0.476
GnomAD4 exome
AF:
0.453
AC:
633567
AN:
1399642
Hom.:
146101
Cov.:
34
AF XY:
0.447
AC XY:
308699
AN XY:
690788
show subpopulations
African (AFR)
AF:
0.353
AC:
11214
AN:
31728
American (AMR)
AF:
0.613
AC:
21896
AN:
35722
Ashkenazi Jewish (ASJ)
AF:
0.501
AC:
12524
AN:
24990
East Asian (EAS)
AF:
0.312
AC:
11315
AN:
36278
South Asian (SAS)
AF:
0.294
AC:
23419
AN:
79616
European-Finnish (FIN)
AF:
0.360
AC:
17985
AN:
49890
Middle Eastern (MID)
AF:
0.514
AC:
2912
AN:
5662
European-Non Finnish (NFE)
AF:
0.470
AC:
506320
AN:
1077676
Other (OTH)
AF:
0.447
AC:
25982
AN:
58080
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
15068
30137
45205
60274
75342
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15176
30352
45528
60704
75880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.426
AC:
64500
AN:
151558
Hom.:
14141
Cov.:
31
AF XY:
0.420
AC XY:
31110
AN XY:
74044
show subpopulations
African (AFR)
AF:
0.349
AC:
14427
AN:
41350
American (AMR)
AF:
0.552
AC:
8383
AN:
15186
Ashkenazi Jewish (ASJ)
AF:
0.503
AC:
1745
AN:
3466
East Asian (EAS)
AF:
0.317
AC:
1613
AN:
5086
South Asian (SAS)
AF:
0.287
AC:
1384
AN:
4814
European-Finnish (FIN)
AF:
0.353
AC:
3727
AN:
10560
Middle Eastern (MID)
AF:
0.551
AC:
162
AN:
294
European-Non Finnish (NFE)
AF:
0.467
AC:
31636
AN:
67784
Other (OTH)
AF:
0.491
AC:
1034
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1839
3678
5518
7357
9196
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
590
1180
1770
2360
2950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.456
Hom.:
3966
Bravo
AF:
0.444
Asia WGS
AF:
0.351
AC:
1220
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Jul 08, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 21, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Catecholaminergic polymorphic ventricular tachycardia 1 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Catecholaminergic polymorphic ventricular tachycardia 5 Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.083
DANN
Benign
0.25
PhyloP100
-0.93
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7754205; hg19: chr6-123539904; COSMIC: COSV107392648; API